Effect of sorafenib for hepatocellualr carcinoma

Trial Profile

Effect of sorafenib for hepatocellualr carcinoma

Phase of Trial: Phase II

Latest Information Update: 13 May 2016

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 May 2016 New trial record
    • 17 Apr 2016 Results (n=12) assessing the complete response and dermatological adverse events presented at The International Liver Congress™ 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top